Key result
Elevated arterial stiffness (baPWV ≥1,750 cm/s) was associated with a significantly lower event-free survival rate for heart failure re-admission and cardiac death compared to low baPWV (P<0.05).
Why the study?
Does elevated arterial stiffness (measured by baPWV) predict re-admission or cardiac death in patients with heart failure?
Cohort (n=72)
Does elevated arterial stiffness (measured by baPWV) predict re-admission or cardiac death in patients with heart failure?
p-value: p=<0.05
Elevated arterial stiffness, measured by baPWV ≥1,750 cm/s, is a significant predictor of heart failure readmission and cardiac death.
No takes yet. Share an insight, caveat, or question.
baPWV may aid HF risk stratification; hypothesis-generating and should not yet change practice.
Meguro et al. (2009) conducted a cohort in Heart failure (n=72). High brachial-ankle pulse wave velocity (baPWV ≥1,750 cm/s) vs. Low baPWV (<1,750 cm/s) was evaluated on Re-admission because of HF (p=<0.05). Elevated arterial stiffness (baPWV ≥1,750 cm/s) was associated with a significantly lower event-free survival rate for heart failure re-admission and cardiac death compared to low baPWV (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: